Nice fantasy. Merck has done multiple biotech acquisitions, is very knowledgeable on NWBO's dubious trials and has shown no interest in a deal with NWBO. That also goes for many other BP. There hasn't been a single BP deal with a OTC biotech penny stock company.
Market Data 
Markets 
AI
